cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Targeting CD38-dependent metabolism to mitigate multiple organ fibrosis A systems-approach to NAD+ restoration
A systems approach to NAD+ restoration ScienceDirect NNMT inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports Nicotinamide Riboside and CD38: Covalent Inhibition and Live Cell Labeling JACS Au Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



